Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery

Life Sciences

Volumn 80, Issue 17, 2007, Pages 1619-1626

  Varadi, Judit ^a   Lekli, Istvan ^a   Juhasz, Bela ^a   Bacskay, Ildiko ^a   Szabo, Gergo ^a   Gesztelyi, Rudolf ^a   Szendrei, Levente ^a   Varga, Edit ^a   Bak, Istvan ^a   Foresti, Roberta ^b   Motterlini, Roberto ^b   Tosaki, Arpad ^a  

^a Faculty of Pharmacy   (Hungary)

^b NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Carbon monoxide; Cardiac function; Heart; Ischemia; Reperfusion

Indexed keywords

CALCIUM ION; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 3; CARDIOVASCULAR AGENT; HEME OXYGENASE 1; POTASSIUM ION; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY; STATISTICAL ANALYSIS; TACHYCARDIA;

ANIMALS; CALCIUM; CARBON MONOXIDE; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HEART RATE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PERFUSION; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RUTHENIUM; SODIUM; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

RATTUS;

EID: 33947097912     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.047     Document Type: Article

References (60)

1. Alto L.E., and Dhalla N.S. Myocardial cation contents during induction of calcium paradox. American Journal of Physiology 237 6 (1979) H713-H719
2. Avkiran M., and Haworth R.S. Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance. Cardiovascular Research 57 4 (2003) 942-952
3. Bak I., Papp G., Turoczi T., Varga E., Szendrei L., Vecsernyes M., Joo F., and Tosaki A. The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radical Biology and Medicine 33 5 (2002) 639-648
4. Bak I., Szendrei L., Turoczi T., Papp G., Joo F., Das D.K., de Leiris J., Der P., Juhasz B., Varga E., Bacskay I., Balla J., Kovacs P., and Tosaki A. Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB Journal 17 14 (2003) 2133-2135
5. Bak I., Varadi J., Nagy N., Vecsernyes M., and Tosaki A. The role of exogenous carbon monoxide in the recovery of post-ischemic cardiac function in buffer perfused isolated rat hearts. Cellular and Molecular Biology (Noisy-le-grand, France) 51 5 (2005) 453-459
6. Bolli R., Becker L., Gross G., Mentzer Jr. R., Balshaw D., and Lathrop D.A. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circulation Research 95 2 (2004) 125-134
7. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., and Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. The Journal of Experimental Medicine 192 7 (2000) 1015-1026
8. Clark J.E., Foresti R., Sarathchandra P., Kaur H., Green C.J., and Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. American Journal of Physiology. Heart and Circulatory Physiology 278 2 (2000) H643-H651
9. Clark J.E., Naughton P., Shurey S., Green C.J., Johnson T.R., Mann B.E., Foresti R., and Motterlini R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circulation Research 93 2 (2003) e2-e8
10. Das D.K., Engelman R.M., Maulik N., Rousou J.A., Flack III J.E., and Deaton D.W. Molecular targets of gene therapy. The Annals of Thoracic Surgery 68 5 (1999) 1929-1933
11. Desmard M., Amara M., Lanone S., Motterlini R., and Boczkowski J. Carbon monoxide reduces the expression and activity of matrix metalloproteinases 1 and 2 in alveolar epithelial cells. Cellular and Molecular Biology (Noisy-le-grand, France) 51 4 (2005) 403-408
12. Dickson E.W., Blehar D.J., Carraway R.E., Heard S.O., Steinberg G., and Przyklenk K. Naloxone blocks transferred preconditioning in isolated rabbit hearts. Journal Molecular Cellular Cardiology 33 9 (2001) 1751-1756
13. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. British Journal of Pharmacology 138 4 (2003) 532-543
14. Fisher P.W., Salloum F., Das A., Hyder H., and Kukreja R.C. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 111 13 (2005) 1601-1610
15. Foresti R., and Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radical Research 31 6 (1999) 459-475
16. Foresti R., Green C.J., and Motterlini R. Generation of bile pigments by heme oxygenase: a refined cellular stratagem in response to stressful insults. Biochemical Society Symposium 71 (2004) 177-192
17. Foresti R., Hammad J., Clark J.E., Johnson R.A., Mann B.E., Friebe A., Green C.J., and Motterlini R. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. British Journal of Pharmacology 142 3 (2004) 453-460
18. Fujimoto H., Ohno M., Ayabe S., Kobayashi H., Ishizaka N., Kimura H., Yoshida K.I., and Nagai R. Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 24 10 (2004) 1848-1853
19. Giannini L., Vannacci A., Fabrizi F., Uliva C., Bani D., Masini E., and Mannaioni P.F. Protection from cardiac injury by induction of heme oxygenase-1 and nitric oxide synthase in a focal ischemia-reperfusion model. Cellular and Molecular Biology (Noisy-le-grand) 51 4 (2005) 393-401
20. Gorman D., Drewry A., Huang Y.L., and Sames C. The clinical toxicology of carbon monoxide. Toxicology 187 1 (2003) 25-38
21. Guo Y., Stein A.B., Wu W.J., Tan W., Zhu X., Li Q.H., Dawn B., Motterlini R., and Bolli R. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. American Journal of Physiology. Heart and Circulatory Physiology 286 5 (2004) H1649-H1653
22. Hearse D.J., and Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovascular Research 26 2 (1992) 101-108
23. Imahashi K., Schneider M.D., Steenbergen C., and Murphy E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circulation Research 95 7 (2004) 734-741
24. Imahashi K., Pott C., Goldhaber J.I., Steenbergen C., Philipson K.D., and Murphy E. Cardiac-specific ablation of the Na+-Ca2+ exchanger confers protection against ischemia/reperfusion injury. Circulation Research 97 9 (2005) 916-921
25. Jaggar J.H., Leffler C.W., Cheranov S.Y., Tcheranova D.E.S., and Cheng X. Carbon monoxide dilates cerebral arterioles by enhancing the coupling of Ca2+ sparks to Ca2+- activated K+ channels. Circulation Research 91 7 (2002) 610-617
26. Jaggar J.H., Li A., Parfenova H., Liu J., Umstot E.S., Dopico A.M., and Leffler C.W. Heme is a carbon monoxide receptor for large-conductance Ca2+-activated K+ channels. Circulation Research 97 8 (2005) 805-812
27. Kim H.P., Ryter S.W., and Choi A.M. CO as a cellular signaling molecule. Annual Review of Pharmacology and Toxicology 46 (2006) 411-449
28. Lopez-Barneo J., and Castellano A. Multiple facets of maxi-K+ channels: the heme connection. The Journal of General Physiology 126 1 (2005) 1-5
29. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annual Review of Pharmacology and Toxicology 37 (1997) 517-554
30. Manning A.S., and Hearse D.J. Reperfusion-induced arrhythmias: mechanisms and prevention. Journal of Molecular and Cellular Cardiology 16 6 (1984) 497-518
31. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. The New England Journal of Medicine 312 3 (1985) 159-163
32. Melo L.G., Agrawal R., Zhang L., Rezvani M., Mangi A.A., Ehsan A., Griese D.P., Dell'Acgua G., Mann M.J., Oyama J., Yet S.F., Layne M.D., Perella M.A., and Dzau V.J. Gene therapy strategy for long term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase. Circulation 105 5 (2002) 602-607
33. Motterlini R., Clark J.E., Foresti R., Sarathchandra P., Mann B.E., and Green C.J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circulation Research 90 2 (2002) E17-E24
34. Motterlini R., Green C.J., and Foresti R. Regulation of heme oxygenase-1 by redox signals involving nitric oxide. Antioxidants and Redox Signalling 4 4 (2002) 615-624
35. Motterlini R., Mann B.E., Johnson T.R., Clark J.E., Foresti R., and Green C.J. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Current Pharmaceutical Design 9 30 (2003) 2525-2539
36. Motterlini R., Mann B.E., and Foresti R. Therapeutic applications of carbon monoxide-releasing molecules (CO-RMs). Expert Opinion on Investigational Drugs 14 11 (2005) 1305-1318
37. Motterlini R., Sawle P., Bains S., Hammad J., Alberto R., Foresti R., and Green C.J. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB Journal 19 2 (2005) 284-286
38. Myers M.L., Bolli R., Lekich R.F., Hartley C.J., and Roberts R. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation 72 4 (1985) 915-921
39. Naughton P., Foresti R., Bains S., Hoque M., Green C.J., and Motterlini R. Induction of heme oxygenase-1 by nitrosative stress: a role for nitroxyl anion. The Journal of Biological Chemistry 277 43 (2002) 40666-40674
40. Opie L.H. Drugs and the heart. IV. Antiarrhythmic agents. Lancet 1 8173 (1980) 861-868
41. Opie L.H. Reperfusion injury and its pharmacologic modification. Circulation 80 4 (1989) 1049-1062
42. Opie L.H. Proposed role of calcium in reperfusion injury. International Journal of Cardiology 23 2 (1989) 159-164
43. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., and Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine 6 4 (2000) 422-428
44. Pridjian A.K., Levitsky S., Krukenkamp I., Silverman N.A., and Feinberg H. Developmental changes in reperfusion injury: a comparison of intracellular cation accumulation in the newborn, neonatal, and adult heart. The Journal of Thoracic and Cardiovascular Surgery 93 3 (1987) 428-433
45. Sandouka A., Balogun E., Foresti R., Mann B.E., Johnson T.R., Tayem Y., Green C.J., Fuller B., and Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) modulate respiration in isolated mitochondria. Cellular and Molecular Biology (Noisy-le-grand, France) 51 4 (2005) 425-432
46. Sandouka A., Fuller B.J., Mann B.E., Green C.J., Foresti R., and Motterlini R. Treatment with carbon monoxide-releasing molecules (CO-RMs) during cold storage improves renal function at reperfusion. Kidney International 69 2 (2006) 239-247
47. Sawle P., Foresti R., Mann B.E., Johnson T.R., Green C.J., and Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. British Journal of Pharmacology 145 6 (2005) 800-810
48. Schultz J.E., Yao Z., Cavero I., and Gross G.J. Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. American Journal of Physiology. Heart and Circulatory Physiology 272 6 (1997) H2607-H2615
49. Sharma H.S., Das D.K., and Verdouw P.D. Enhanced expression and localization of hemeoxygenase-1 during recovery phase of porcine stunned myocardium. Molecular and Cellular Biochemistry 196 1-2 (1999) 133-139
50. Shivkumar K., Deutsch N.A., Lamp S.T., Khuu K., Goldhaber J.I., and Weiss J.N. Mechanism of hypoxic K loss in rabbit ventricle. The Journal of Clinical Investigation 100 7 (1997) 1782-1788
51. Stein A.B., Guo Y., Tan W., Wu W.J., Zhu X., Li Q., Luo C., Dawn B., Johnson T.R., Motterlini R., and Bolli R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. Journal of Molecular and Cellular Cardiology 38 1 (2005) 127-134
52. Szabo M.E., Haines D.D., Garay E., Chiavaroli C., Farine J.C., Hannaert P., Berta A., and Garay R.P. Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina. European Journal of Pharmacology 428 2 (2001) 277-286
53. Szendrei L., Turoczi T., Kovacs P., Vecsernyes M., Das D.K., and Tosaki A. Mitochondrial gene expression and ventricular fibrillation in ischemic/reperfused nondiabetic and diabetic myocardium. Biochemical Pharmacology 63 3 (2002) 543-552
54. Taille C., El-Benna J., Lanone S., Boczkowski J., and Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. The Journal of Biological Chemistry 280 27 (2005) 25350-25360
55. Tang X.D., Xu R., Reynolds M.F., Garcia M.L., Heinemann S.H., and Hoshi T. Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 425 6957 (2003) 531-535
56. Tayem Y., Johnson T.R., Mann B.E., Green C.J., and Motterlini R. Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. American Journal of Physiology. Renal Physiology 290 4 (2006) F789-F794
57. Tosaki A., and Hearse D.J. Protective effect of transient calcium reduction against reperfusion-induced arrhythmias in rat hearts. American Journal of Physiology 253 2 Pt 2 (1987) H225-H233
58. Tosaki A., Balint S., and Szekeres L. Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium, and calcium content. Journal of Cardiovascular Pharmacology 12 6 (1988) 621-628
59. Venkatesh N., Stuart J.S., Lamp S.T., Alexander L.D., and Weiss J.N. Activation of ATP-sensitive K channels by cromakalim - effects of cellular K loss and cardiac function in ischemic and reperfused mammalian ventricle. Circulation Research 71 6 (1992) 1324-1333
60. Vulapalli S.R., Chen Z., Chua B.H., Wang T., and Liang C.S. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. American Journal of Physiology. Heart and Circulatory Physiology 283 2 (2002) H688-H694